MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Brain structure alternations and disrupted functional connectivity in paroxysmal kinesigenic dyskinesia

    Y. Liu, C. Chen, P. Wang, Y. Chen, C. Lin, S. Kwan, C. Chou, D. Yen, Y. Wu (北投區, Taiwan)

  • BRAT1 associated neurodegeneration and review of literature

    V. Cerino Palomino, T. Ortegano Briones, D. Tristán Samaniego, C. Zepeda Salazar, C. Torres Vázquez, R. Abundes Corona, G. Cervantes Arriaga, M. Rodríguez Violante (Mexico City, Mexico)

  • Bullous skin lesions following introduction of safinamide in a woman with Parkinson’s disease

    L. Lachance, P. Huot (Montreal, Canada)

  • Burden of COVID-19 among patients with Parkinson’s disease and associated clinical outcomes: Evidence from a meta-analysis

    S. Hussain (Brno, Czech Republic)

  • C-SURF: DBS programming using probabilistic maps as an efficient new approach to treat patients with dystonia: the results of a feasibility study.

    F. Lange, M. Reich (Würzburg, Germany)

  • Can abdominal internal oblique muscle be a possible target for ultrasound-guided Botulinum toxin injection in patients with Parkinson’s Disease affected by axials problems? An ultrasound study of our case series.

    F. Marenco, P. Arcuri, M. Meloni, M. Ramella, A. Castagna (Milan, Italy)

  • Can membrane association of α-synuclein aggregates lead to stress in the astrocytic endoplasmic reticulum?

    A. Raj, I. Datta, R. Banerjee (Bangalore, India)

  • Can treatment of Helicobacter pylori decrease Parkinson’s disease risk?

    L. Eisenberg, N. Giladi, V. Rozani, C. Peretz (Tel Aviv, Israel)

  • Can we add whey protein supplementation in patients with Parkinson’s disease without interfering with levodopa response?

    G. Pinelli, C. Siri, A. Ranghetti, V. Cereda, R. Maestri, M. Canesi (Gravedona, Italy)

  • Cannabinoids for painful dystonia in corticobasal syndrome: a report of three patients

    G. Rizzo, P. Avoni, V. Donadio, R. Liguori (Bologna, Italy)

  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 153
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley